According to TechSci Research report, “Malaria Vaccine Market – Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028”, Global Malaria Vaccine Market is expected to grow during the forecast period of 2024-2028. This can be ascribed to the increasing incidences of malaria, rising R&D activities, and growing healthcare expenditure.
Global malaria vaccine market is being driven by several factors, including increasing investment in research and development of vaccines, the growing burden of malaria in endemic regions, and the rising demand for effective malaria prevention measures. The development of innovative vaccine technologies and advances in understanding the complex nature of the malaria parasite are also driving the growth of the market. In addition, government initiatives and partnerships between public and private sectors to combat malaria are creating new opportunities for vaccine manufacturers. Finally, the increasing awareness of the importance of vaccination and the potential benefits of a malaria vaccine are also contributing to the growth of the market. These factors are expected to continue to drive the growth of the global malaria vaccine market in the coming years.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on “Malaria Vaccine Market.”- https://www.techsciresearch.com/report/malaria-vaccine-market/14997.html
Global Malaria Vaccine Market can be segmented by vaccine type, by route of administration, and by region.
Based on vaccine type, Global Malaria Vaccine Market can be divided into Pre-Erythrocytic, Erythrocytic, Multi-antigen, and Others. The pre-erythrocytic segment is expected to dominate the global malaria vaccine market in the coming years due to the effectiveness of pre-erythrocytic vaccines in preventing malaria infections. Pre-erythrocytic vaccines target the early stages of the malaria parasite’s life cycle, which is when it infects the liver and begins to replicate. By targeting this stage of the infection, pre-erythrocytic vaccines can prevent the parasite from causing symptoms and reduce the spread of the disease. Additionally, pre-erythrocytic vaccines have shown promising results in clinical trials and are in advanced stages of development. Several leading vaccine candidates in the pre-erythrocytic segment are currently undergoing clinical trials, indicating a significant focus on this area of the market. Therefore, the pre-erythrocytic segment is expected to continue dominating the global malaria vaccine market in the coming years.
Global Malaria Vaccine Market is divided into North America, Europe, Asia Pacific, South America and Middle East & Africa, based on region. The Middle East and Africa region is expected to dominate the global malaria vaccine market in the coming years due to the high prevalence of malaria in the region. Sub-Saharan Africa, in particular, bears a significant burden of the disease. As a result, there is a high demand for effective malaria prevention measures, including vaccines, in this region. Additionally, several key market players, including GlaxoSmithKline and Sanofi, have a strong presence in the region and are actively involved in malaria vaccine research and development. Furthermore, government initiatives aimed at combating malaria and increasing access to healthcare in the region are expected to drive the growth of the market. Therefore, the Middle East and Africa region is likely to dominate the global malaria vaccine market in the coming years.
Major companies operating in Global Malaria Vaccine Market are:
- GlaxoSmithKline Plc.
- Novartis AG
- Takeda Pharmaceutical Company
- Sanaria Inc.
- Merck & Co.
- Johnson & Johnson
- Pfizer Inc.
- Serum Institute of India Private Limited
- Bharat Biotech International Limited
- Moderna Inc
Download Free Sample Report
Customers can also request for 10% free customization on this report.
“Global malaria vaccine market is rapidly evolving, with significant advancements in vaccine technology and an increasing number of clinical trials for malaria vaccines. The market is dominated by pre-erythrocytic vaccines, which target the early stages of the malaria parasite’s life cycle and have shown promising results in clinical trials. There is also a growing focus on multi-stage vaccines that target multiple stages of the parasite’s life cycle, potentially leading to increased efficacy. Technological advancements, such as the use of virus-like particles and adjuvants, are also driving the development of more effective vaccines. Additionally, there is a growing emphasis on the need for vaccines that are effective against all strains of the parasite, including drug-resistant strains. The increasing number of clinical trials and partnerships between public and private sectors bodes well for the future of the malaria vaccine market, with several promising vaccine candidates currently in advanced stages of development.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Malaria Vaccine Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Vaccine Type (Pre-Erythrocytic, Erythrocytic, Multi-antigen, Others), By Route of Administration (Intramuscular, Subcutaneous, Intradermal, Others), Region and Competition”, has evaluated the future growth potential of Global Malaria Vaccine Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Malaria Vaccine Market.
Download Free Sample Report- https://www.techsciresearch.com/sample-report.aspx?cid=14997
Related Reports:
Apac artificial organs and bionics market
About TechSci Research:
TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Web: https://www.techsciresearch.com